Parainfluenza virus vaccine live intranasal - Wyeth
Alternative Names: cp45 PIV-3Latest Information Update: 24 Oct 2021
At a glance
- Originator Wyeth
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parainfluenza virus infections
Most Recent Events
- 06 Jun 2002 Phase-I clinical trials for Respiratory syncytial virus and parainfluenza virus infections in USA (intranasal)
- 26 Mar 2002 American Home Products has changed its name and the names of its subsidiaries Wyeth-Ayerst and Wyeth-Lederle to Wyeth
- 31 Dec 2001 Phase-I clinical trials for Parainfluenza virus infections in USA (Intranasal)